Cullinan Therapeutics Inc (CGEM)
26.56
-0.61
(-2.25%)
USD |
NASDAQ |
May 10, 16:00
27.09
+0.53
(+2.00%)
After-Hours: 20:00
Cullinan Therapeutics Price: 26.56 for May 10, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 09, 2024 | 27.33 | 29.08 | 26.96 | 27.17 | 1.149M |
May 08, 2024 | 29.00 | 29.29 | 27.60 | 27.72 | 1.032M |
May 07, 2024 | 28.40 | 30.19 | 27.91 | 29.35 | 873483.0 |
May 06, 2024 | 28.40 | 28.85 | 27.34 | 28.40 | 767160.0 |
May 03, 2024 | 27.88 | 29.25 | 27.88 | 28.35 | 975213.0 |
May 02, 2024 | 28.22 | 28.22 | 26.73 | 27.58 | 986391.0 |
May 01, 2024 | 27.54 | 28.99 | 27.30 | 28.10 | 1.442M |
Apr 30, 2024 | 27.15 | 28.03 | 26.34 | 27.01 | 1.420M |
Apr 29, 2024 | 25.62 | 29.12 | 25.60 | 27.12 | 2.703M |
Apr 26, 2024 | 19.27 | 25.72 | 19.27 | 25.30 | 4.748M |
Apr 25, 2024 | 18.50 | 19.43 | 18.23 | 19.25 | 1.550M |
Apr 24, 2024 | 16.69 | 19.55 | 16.53 | 18.89 | 1.174M |
Apr 23, 2024 | 15.44 | 16.90 | 15.44 | 16.67 | 966393.0 |
Apr 22, 2024 | 15.63 | 16.32 | 15.29 | 15.63 | 968160.0 |
Apr 19, 2024 | 18.00 | 18.26 | 15.20 | 15.66 | 1.179M |
Apr 18, 2024 | 18.00 | 19.19 | 17.95 | 18.06 | 702321.0 |
Apr 17, 2024 | 18.01 | 19.98 | 17.61 | 17.88 | 1.261M |
Apr 16, 2024 | 19.87 | 20.62 | 16.87 | 17.32 | 3.354M |
Apr 15, 2024 | 17.38 | 17.55 | 16.32 | 16.55 | 202457.0 |
Apr 12, 2024 | 17.30 | 17.57 | 16.52 | 16.67 | 185126.0 |
Apr 11, 2024 | 17.46 | 17.46 | 16.74 | 17.37 | 227921.0 |
Apr 10, 2024 | 16.60 | 17.34 | 16.53 | 17.06 | 233314.0 |
Apr 09, 2024 | 17.16 | 17.92 | 16.90 | 17.03 | 469571.0 |
Apr 08, 2024 | 16.04 | 17.14 | 16.03 | 17.00 | 491807.0 |
Apr 05, 2024 | 16.65 | 17.37 | 16.15 | 17.02 | 247968.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
7.31
Minimum
May 11 2022
53.42
Maximum
Mar 10 2021
17.30
Average
13.07
Median
Sep 13 2022
Price Benchmarks
Fate Therapeutics Inc | 4.085 |
Viking Therapeutics Inc | 73.66 |
Allogene Therapeutics Inc | 2.755 |
Applied Therapeutics Inc | 4.395 |
Nkarta Inc | 6.27 |
Price Related Metrics
Price to Book Value | 2.521 |
Earnings Yield | -13.89% |
Market Cap | 1.144B |